RESMED INC (RMD) Options Risk Score

Run a full RMD options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on RESMED INC (RMD) right now?

Over a 4-week expiry window, RESMED INC (RMD) scores 73 out of 100 for options catalyst risk (HIGH). What pushes it there: an upcoming earnings report, 7 recent news items, 3 active legal filings and 11 clinical-trial catalysts, all landing inside the 4-week window. A HIGH reading (70+) means RMD has a dated event inside the window, so an option sold here carries gap risk that time decay alone will not pay for. The score ranks event exposure, not the likely direction of the move.

RMD shows an IV Rank of 59, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 39%. IV Rank is the most useful figure for deciding whether to sell or buy premium on RMD.

RMD reports on 2026-10-29. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.

RESMED INC (RMD) current implied volatility and IV Rank

RESMED INC (RMD) currently has an IV Rank of 59 with implied volatility around 39%, alongside a TickerRisk options-risk score of 73/100. RMD's options are priced near the middle of their own yearly range — unremarkable volatility, so the trade has to stand on its own thesis rather than on rich or cheap premium.

Unsure how to act on this? What IV Rank is worth selling at →

RESMED INC (RMD) next earnings date — 2026-10-29

RESMED INC (RMD) reports earnings on 2026-10-29 — about 7 days away, which falls inside a typical options expiry window. RMD's IV Rank is currently 59. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer